Advanced Biomed Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ADVB | 8YY.SI | BIAF | ISPC | IMDX | BDSX | |
|---|---|---|---|---|---|---|
| Market cap | 3.47M | 41.60M | 3.76M | 2.12M | 86.72M | 226.74M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | — | -4.9 | -1.1 | -3.3 | -97.7 |
| Price/book | 0.3 | 24.0 | 0.4 | 0.7 | -4.1 | 24.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −75.17% | +13.64% | −90.20% | −96.70% | −58.86% | +144.77% |
| Today | −4.55% | −4.00% | −8.15% | +6.75% | −3.28% | +2.09% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All ADVB news ›Reviewing The9 (NASDAQ:NCTY) & Advanced Biomed (NASDAQ:ADVB)
Posted by Mitch Edgeman on Oct 27th, 2026 The9 (NASDAQ:NCTY – Get Free Report) and Advanced Biomed (NASDAQ:ADVB – Get Free Report) are both small-cap technology companies, but which is the better investment? We will contrast the two…
AEye: Orin Hirschman reports 8.3% passive stake
Investment firms and a family hold 3.86M AEye (LIDR) shares in a reported passive stake. Stock Titan - [SCHEDULE 13G] AEye, Inc. Passive Investment Disclosure (>5%) AEye: Orin Hirschman reports 8.3% passive stake The ownership disclosure…
Advanced Biomed (NASDAQ:ADVB) Stock Gets Downgrade from Wall Street Zen
Posted by Mitch Edgeman on Oct 17th, 2026 Advanced Biomed (NASDAQ:ADVB – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday, Wall…
DevvStream investor reports 14.07% passive stake
One investor reports sole voting power over 7.35M DevvStream (DEVSF) shares. Stock Titan - [SCHEDULE 13G] DevvStream Corp. Passive Investment Disclosure (>5%) DevvStream investor reports 14.07% passive stake The reported 14.07% interest is…
Advanced Biomed FY2026 continuing loss widens to $6.26M
Qualcomm Statement on Trial Verdict Win Fiscal 2026 net income included a $14,015,417 subsidiary-disposal gain, alongside a $6,261,276 loss from continuing operations. Advanced Biomed Inc. completed its shift from biomedical operations to…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net3
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.